Patient In-vivo Dosimetry (IVD) System Market, Global Outlook and Forecast 2024-2031

Report ID: 1212414 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Patient In-vivo Dosimetry (IVD) System Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Patient In-vivo Dosimetry (IVD) System Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Patient In-vivo Dosimetry (IVD) System Overall Market Size
    2.1 Global Patient In-vivo Dosimetry (IVD) System Market Size: 2021 VS 2028
    2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Patient In-vivo Dosimetry (IVD) System Sales: 2017-2028
3 Company Landscape
    3.1 Top Patient In-vivo Dosimetry (IVD) System Players in Global Market
    3.2 Top Global Patient In-vivo Dosimetry (IVD) System Companies Ranked by Revenue
    3.3 Global Patient In-vivo Dosimetry (IVD) System Revenue by Companies
    3.4 Global Patient In-vivo Dosimetry (IVD) System Sales by Companies
    3.5 Global Patient In-vivo Dosimetry (IVD) System Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Patient In-vivo Dosimetry (IVD) System Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Patient In-vivo Dosimetry (IVD) System Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Patient In-vivo Dosimetry (IVD) System Players in Global Market
        3.8.1 List of Global Tier 1 Patient In-vivo Dosimetry (IVD) System Companies
        3.8.2 List of Global Tier 2 and Tier 3 Patient In-vivo Dosimetry (IVD) System Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Patient In-vivo Dosimetry (IVD) System Market Size Markets, 2021 & 2028
        4.1.2 Portable
        4.1.3 Fixed
    4.2 By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue & Forecasts
        4.2.1 By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2022
        4.2.2 By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue, 2023-2028
        4.2.3 By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    4.3 By Type - Global Patient In-vivo Dosimetry (IVD) System Sales & Forecasts
        4.3.1 By Type - Global Patient In-vivo Dosimetry (IVD) System Sales, 2017-2022
        4.3.2 By Type - Global Patient In-vivo Dosimetry (IVD) System Sales, 2023-2028
        4.3.3 By Type - Global Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    4.4 By Type - Global Patient In-vivo Dosimetry (IVD) System Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Patient In-vivo Dosimetry (IVD) System Market Size, 2021 & 2028
        5.1.2 Medical
        5.1.3 Scientific Research
        5.1.4 Others
    5.2 By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue & Forecasts
        5.2.1 By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2022
        5.2.2 By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue, 2023-2028
        5.2.3 By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    5.3 By Application - Global Patient In-vivo Dosimetry (IVD) System Sales & Forecasts
        5.3.1 By Application - Global Patient In-vivo Dosimetry (IVD) System Sales, 2017-2022
        5.3.2 By Application - Global Patient In-vivo Dosimetry (IVD) System Sales, 2023-2028
        5.3.3 By Application - Global Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    5.4 By Application - Global Patient In-vivo Dosimetry (IVD) System Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Patient In-vivo Dosimetry (IVD) System Market Size, 2021 & 2028
    6.2 By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue & Forecasts
        6.2.1 By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2022
        6.2.2 By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue, 2023-2028
        6.2.3 By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    6.3 By Region - Global Patient In-vivo Dosimetry (IVD) System Sales & Forecasts
        6.3.1 By Region - Global Patient In-vivo Dosimetry (IVD) System Sales, 2017-2022
        6.3.2 By Region - Global Patient In-vivo Dosimetry (IVD) System Sales, 2023-2028
        6.3.3 By Region - Global Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2028
        6.4.2 By Country - North America Patient In-vivo Dosimetry (IVD) System Sales, 2017-2028
        6.4.3 US Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.4.4 Canada Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.4.5 Mexico Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2028
        6.5.2 By Country - Europe Patient In-vivo Dosimetry (IVD) System Sales, 2017-2028
        6.5.3 Germany Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.5.4 France Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.5.5 U.K. Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.5.6 Italy Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.5.7 Russia Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.5.8 Nordic Countries Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.5.9 Benelux Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2028
        6.6.2 By Region - Asia Patient In-vivo Dosimetry (IVD) System Sales, 2017-2028
        6.6.3 China Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.6.4 Japan Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.6.5 South Korea Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.6.6 Southeast Asia Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.6.7 India Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2028
        6.7.2 By Country - South America Patient In-vivo Dosimetry (IVD) System Sales, 2017-2028
        6.7.3 Brazil Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.7.4 Argentina Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales, 2017-2028
        6.8.3 Turkey Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.8.4 Israel Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.8.5 Saudi Arabia Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
        6.8.6 UAE Patient In-vivo Dosimetry (IVD) System Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Landauer
        7.1.1 Landauer Corporate Summary
        7.1.2 Landauer Business Overview
        7.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.1.4 Landauer Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.1.5 Landauer Key News
    7.2 Chiyoda Technol Corporation
        7.2.1 Chiyoda Technol Corporation Corporate Summary
        7.2.2 Chiyoda Technol Corporation Business Overview
        7.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.2.4 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.2.5 Chiyoda Technol Corporation Key News
    7.3 Mirion Technologies
        7.3.1 Mirion Technologies Corporate Summary
        7.3.2 Mirion Technologies Business Overview
        7.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.3.4 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.3.5 Mirion Technologies Key News
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Corporate Summary
        7.4.2 Thermo Fisher Scientific Business Overview
        7.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.4.4 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.4.5 Thermo Fisher Scientific Key News
    7.5 Fuji Electric
        7.5.1 Fuji Electric Corporate Summary
        7.5.2 Fuji Electric Business Overview
        7.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.5.4 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.5.5 Fuji Electric Key News
    7.6 Hitachi Aloka
        7.6.1 Hitachi Aloka Corporate Summary
        7.6.2 Hitachi Aloka Business Overview
        7.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.6.4 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.6.5 Hitachi Aloka Key News
    7.7 Bertin Instruments
        7.7.1 Bertin Instruments Corporate Summary
        7.7.2 Bertin Instruments Business Overview
        7.7.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.7.4 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.7.5 Bertin Instruments Key News
    7.8 Tracerco
        7.8.1 Tracerco Corporate Summary
        7.8.2 Tracerco Business Overview
        7.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.8.4 Tracerco Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.8.5 Tracerco Key News
    7.9 ATOMTEX
        7.9.1 ATOMTEX Corporate Summary
        7.9.2 ATOMTEX Business Overview
        7.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.9.4 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.9.5 ATOMTEX Key News
    7.10 Panasonic
        7.10.1 Panasonic Corporate Summary
        7.10.2 Panasonic Business Overview
        7.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.10.4 Panasonic Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.10.5 Panasonic Key News
    7.11 Polimaster
        7.11.1 Polimaster Corporate Summary
        7.11.2 Polimaster Patient In-vivo Dosimetry (IVD) System Business Overview
        7.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.11.4 Polimaster Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.11.5 Polimaster Key News
    7.12 Renri
        7.12.1 Renri Corporate Summary
        7.12.2 Renri Patient In-vivo Dosimetry (IVD) System Business Overview
        7.12.3 Renri Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.12.4 Renri Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.12.5 Renri Key News
    7.13 RadPro International GmbH
        7.13.1 RadPro International GmbH Corporate Summary
        7.13.2 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Business Overview
        7.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.13.4 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.13.5 RadPro International GmbH Key News
    7.14 Ludlum Measurements
        7.14.1 Ludlum Measurements Corporate Summary
        7.14.2 Ludlum Measurements Business Overview
        7.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.14.4 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.14.5 Ludlum Measurements Key News
    7.15 XZ LAB
        7.15.1 XZ LAB Corporate Summary
        7.15.2 XZ LAB Business Overview
        7.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Major Product Offerings
        7.15.4 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales and Revenue in Global (2017-2022)
        7.15.5 XZ LAB Key News
8 Global Patient In-vivo Dosimetry (IVD) System Production Capacity, Analysis
    8.1 Global Patient In-vivo Dosimetry (IVD) System Production Capacity, 2017-2028
    8.2 Patient In-vivo Dosimetry (IVD) System Production Capacity of Key Manufacturers in Global Market
    8.3 Global Patient In-vivo Dosimetry (IVD) System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Patient In-vivo Dosimetry (IVD) System Supply Chain Analysis
    10.1 Patient In-vivo Dosimetry (IVD) System Industry Value Chain
    10.2 Patient In-vivo Dosimetry (IVD) System Upstream Market
    10.3 Patient In-vivo Dosimetry (IVD) System Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Patient In-vivo Dosimetry (IVD) System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
List of Tables
    Table 1. Key Players of Patient In-vivo Dosimetry (IVD) System in Global Market
    Table 2. Top Patient In-vivo Dosimetry (IVD) System Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Patient In-vivo Dosimetry (IVD) System Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Companies, 2017-2022
    Table 5. Global Patient In-vivo Dosimetry (IVD) System Sales by Companies, (K Units), 2017-2022
    Table 6. Global Patient In-vivo Dosimetry (IVD) System Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Patient In-vivo Dosimetry (IVD) System Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Patient In-vivo Dosimetry (IVD) System Product Type
    Table 9. List of Global Tier 1 Patient In-vivo Dosimetry (IVD) System Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Patient In-vivo Dosimetry (IVD) System Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Patient In-vivo Dosimetry (IVD) System Sales (K Units), 2017-2022
    Table 15. By Type - Global Patient In-vivo Dosimetry (IVD) System Sales (K Units), 2023-2028
    Table 16. By Application – Global Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Patient In-vivo Dosimetry (IVD) System Sales (K Units), 2017-2022
    Table 20. By Application - Global Patient In-vivo Dosimetry (IVD) System Sales (K Units), 2023-2028
    Table 21. By Region – Global Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Patient In-vivo Dosimetry (IVD) System Sales (K Units), 2017-2022
    Table 25. By Region - Global Patient In-vivo Dosimetry (IVD) System Sales (K Units), 2023-2028
    Table 26. By Country - North America Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2017-2022
    Table 29. By Country - North America Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2023-2028
    Table 38. By Country - South America Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2017-2022
    Table 41. By Country - South America Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales, (K Units), 2023-2028
    Table 46. Landauer Corporate Summary
    Table 47. Landauer Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 48. Landauer Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. Chiyoda Technol Corporation Corporate Summary
    Table 50. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 51. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Mirion Technologies Corporate Summary
    Table 53. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 54. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. Thermo Fisher Scientific Corporate Summary
    Table 56. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 57. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. Fuji Electric Corporate Summary
    Table 59. Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 60. Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Hitachi Aloka Corporate Summary
    Table 62. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 63. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. Bertin Instruments Corporate Summary
    Table 65. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 66. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. Tracerco Corporate Summary
    Table 68. Tracerco Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 69. Tracerco Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 70. ATOMTEX Corporate Summary
    Table 71. ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 72. ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 73. Panasonic Corporate Summary
    Table 74. Panasonic Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 75. Panasonic Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 76. Polimaster Corporate Summary
    Table 77. Polimaster Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 78. Polimaster Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 79. Renri Corporate Summary
    Table 80. Renri Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 81. Renri Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 82. RadPro International GmbH Corporate Summary
    Table 83. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 84. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 85. Ludlum Measurements Corporate Summary
    Table 86. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 87. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 88. XZ LAB Corporate Summary
    Table 89. XZ LAB Patient In-vivo Dosimetry (IVD) System Product Offerings
    Table 90. XZ LAB Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 91. Patient In-vivo Dosimetry (IVD) System Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 92. Global Patient In-vivo Dosimetry (IVD) System Capacity Market Share of Key Manufacturers, 2020-2022
    Table 93. Global Patient In-vivo Dosimetry (IVD) System Production by Region, 2017-2022 (K Units)
    Table 94. Global Patient In-vivo Dosimetry (IVD) System Production by Region, 2023-2028 (K Units)
    Table 95. Patient In-vivo Dosimetry (IVD) System Market Opportunities & Trends in Global Market
    Table 96. Patient In-vivo Dosimetry (IVD) System Market Drivers in Global Market
    Table 97. Patient In-vivo Dosimetry (IVD) System Market Restraints in Global Market
    Table 98. Patient In-vivo Dosimetry (IVD) System Raw Materials
    Table 99. Patient In-vivo Dosimetry (IVD) System Raw Materials Suppliers in Global Market
    Table 100. Typical Patient In-vivo Dosimetry (IVD) System Downstream
    Table 101. Patient In-vivo Dosimetry (IVD) System Downstream Clients in Global Market
    Table 102. Patient In-vivo Dosimetry (IVD) System Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Patient In-vivo Dosimetry (IVD) System Segment by Type
    Figure 2. Patient In-vivo Dosimetry (IVD) System Segment by Application
    Figure 3. Global Patient In-vivo Dosimetry (IVD) System Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Patient In-vivo Dosimetry (IVD) System Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Patient In-vivo Dosimetry (IVD) System Revenue, 2017-2028 (US$, Mn)
    Figure 7. Patient In-vivo Dosimetry (IVD) System Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Patient In-vivo Dosimetry (IVD) System Revenue in 2021
    Figure 9. By Type - Global Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 10. By Type - Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 13. By Application - Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 16. By Region - Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 19. US Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 24. Germany Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 25. France Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 33. China Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 37. India Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 40. Brazil Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share, 2017-2028
    Figure 44. Turkey Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Patient In-vivo Dosimetry (IVD) System Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Patient In-vivo Dosimetry (IVD) System Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Patient In-vivo Dosimetry (IVD) System by Region, 2021 VS 2028
    Figure 50. Patient In-vivo Dosimetry (IVD) System Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
117
Frequently Asked Questions
Patient In-vivo Dosimetry System Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Patient In-vivo Dosimetry System Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Patient In-vivo Dosimetry System Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports